SG/CALL/ROCHE GS/350/0.1/20.12.24 Share Price

Warrant

DE000SQ34XC0

Market Closed - Deutsche Boerse AG 01:11:48 21/05/2024 am IST
0.061 EUR -1.61% Intraday chart for SG/CALL/ROCHE GS/350/0.1/20.12.24
Current month+41.86%
1 month+5.17%
Date Price Change
20/24/20 0.061 -1.61%
17/24/17 0.062 -35.42%
16/24/16 0.096 +100.00%
15/24/15 0.048 +11.63%
14/24/14 0.043 -15.69%

Delayed Quote Deutsche Boerse AG

Last update May 21, 2024 at 01:11 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
WKN SQ34XC
ISINDE000SQ34XC0
Date issued 10/11/2022
Strike 350 CHF
Maturity 20/12/2024 (214 Days)
Parity 10 : 1
Emission price 2.77
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.99
Lowest since issue 0.012
Delta0.05x
Omega 12.07
Premium48.02x
Gearing247.07x
Moneyness 0.6774
Difference Strike 112.9 CHF
Difference Strike %+32.26%
Spread 0.066
Spread %50.77%
Intrinsic value 0.000000

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
237.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+17.84%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW